Aurobindo gets 5 product approvals from USFDA

16108 Investors following Aurobindo Pharm. Share this News with them.

0

Like this story, share it with millions of investors on M3

Aurobindo gets 5 product approvals from USFDA

Aurobindo Pharma receives five product approvals from USFDA including two Paragraph IV products. These approvals include two Paragraph IV products - Finasteride Tablets USP and Glyburide & Metformin Hydrochloride Tablets.

Post your opinion here

 

0

Tweet

Share on Tumblr

RELATED NEWS Aurobindo Pharma declares Q2 total income up by 38.9% Aurobindo Pharma receives UK-MHRA clearance for Unit XI Aurobindo Pharma gets EIR for drug formulation facility ALSO READ See latest News about Aurobindo Pharm See previous management interviews See what other Experts & Brokerages are saying about Aurobindo Pharm Aurobindo Pharm BSE | NSE 25/05/12 Are Mutual Funds betting on Aurobindo Pharm?

Aurobindo Pharma Ltd is pleased to announce that it has received 5 product approvals from the US Food & Drug Administration since October 2007 for the US market. These approvals include two Paragraph IV products - Finasteride Tablets USP and Glyburide & Metformin Hydrochloridep; Tablets.

The products approved are as follows:

1. Glyburide Tablets USP - 1.25, 2.5 & 5 mg

2. Torsemide Tablets - 5, 10, 20 and 100 mg

3. Finasteride Tablets USP - 5 mg

4. Atenolol Tablets USP - 25, 50 and 100 mg

5. Glyburide & Metformin Hydrochloride Tablets - 1.25/250, 2.5/500 & 5/500 mg

Aurobindo now has a total of 59 ANDAs approved by the USFDA 

Sourced From: Aurobindo Pharma Limited